Heron Therapeutics, Inc. - Common Stock (HRTX)

Heron Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative product candidates to address unmet medical needs in the treatment of various pain conditions and supportive care for patients undergoing chemotherapy. The company's expertise lies in harnessing proprietary formulations and delivery technologies to improve the efficacy and safety of existing therapies, thereby enhancing the overall patient experience. Heron Therapeutics is dedicated to advancing its pipeline of novel therapeutics aimed at providing effective solutions for managing acute pain and chemotherapy-induced nausea and vomiting, striving to improve the quality of life for patients.